Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...

Biogen Inc. is investing $2 billion in its North Carolina RTP site, expanding manufacturing amid tariff talks.

Biogen will invest an additional $2 billion in its existing manufacturing in North Carolina, the drugmaker said on Monday, as it seeks to expand its presence in the U.S. amid President Donald Trump's ...

Biogen has unveiled plans to invest an additional $2bn in its existing manufacturing footprint in North Carolina, US. The upcoming investment in the state’s Research Triangle Park (RTP), where Biogen ...

The importance of a homegrown biomanufacturing workforce to North Carolina’s swiftly growing life sciences industry was a ...

Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage clinical pipeline support.

North Carolina’s RTP is home to Biogen's largest manufacturing footprint. As the state's largest biotechnology employer and one of the top five biopharmaceutical employers, Biogen employs over ...

Biogen is ramping up in RTP with a fresh $2 billion investment. © 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes ...